Olr22 Inhibitors
Olr22 inhibitors are a diverse group of chemical compounds that modulate the activity of the olfactory receptor Olr22 through various intracellular pathways. For instance, the selective PPARγ antagonist GW9662 may downregulate Olr22 by inhibiting PPARγ, which is known to affect olfactory receptor expression. Similarly, the MEK inhibitor PD98059, the PI3K inhibitor LY294002, and the p38 MAPK inhibitor SB203580 potentially decrease Olr22 activity by blocking key pathways-MAPK/ERK, PI3K/Akt, and p38 MAPK, respectively-that are implicated in the regulatory networks of olfactory receptors. The PLC inhibitor U73122 and the PKC inhibitor Go6983 could attenuate Olr22 function by disrupting second messenger signaling, vital for olfactory receptor-mediated responses. Inhibitors such as ML7 and D4476 target myosin light chain kinase and casein kinase 1, which may lead to altered receptor localization and reduced expression or activity, further demonstrating the intricate link between cytoskeletal dynamics and olfactory receptor function.
The calcium chelator BAPTA-AM might inhibit Olr22 activity by disrupting calcium homeostasis, a critical element of the signaling mechanism for olfactory receptors. In addition, the tyrosine kinase inhibitor Genistein could interfere with phosphorylation processes essential for the function of Olr22. Lastly, XAV-939, a tankyrase inhibitor, indirectly influences Olr22 function by modulating the β-catenin signaling pathway. These inhibitors collectively represent a toolkit capable of targeting Olr22 through multiple biochemical avenues, revealing the complexity of regulatory mechanisms that govern this specific olfactory receptor's activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $70.00 | 30 | |
GW9662 is a selective PPARγ antagonist that inhibits the transcriptional activity of PPARγ. Olr22 activity could be decreased by this compound since PPARγ activation has been implicated in the regulation of olfactory receptor expression and function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that blocks the MAPK/ERK pathway. By inhibiting this pathway, the compound may reduce the expression or activity of Olr22, as MAPK is known to regulate gene expression linked to olfactory functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that may lead to decreased Olr22 activity by blocking the PI3K/Akt pathway, which is involved in the cellular processes that regulate the function of olfactory receptors. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which may indirectly reduce Olr22 activity by inhibiting the p38 MAPK pathway involved in inflammatory responses that can modulate olfactory receptor function. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML7 is an inhibitor of myosin light chain kinase (MLCK) which may lead to decreased Olr22 activity by affecting cytoskeletal dynamics and thus influencing olfactory receptor localization and function. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is a protein kinase C (PKC) inhibitor. By inhibiting PKC, it may decrease the activity of Olr22, as PKC is involved in signal transduction processes that regulate olfactory receptor function and expression. | ||||||
Casein Kinase I Inhibitor, D4476 | 301836-43-1 | sc-202522 | 1 mg | $99.00 | 6 | |
D4476 is a casein kinase 1 (CK1) inhibitor. CK1 is involved in various cellular processes, including regulation of olfactory receptors. Inhibition of CK1 could lead to decreased activity or expression of Olr22. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
KT5720 is a protein kinase A (PKA) inhibitor. By inhibiting PKA, a kinase involved in the cAMP pathway, KT5720 could lead to decreased Olr22 activity or expression, as PKA can regulate olfactory receptor signaling. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a calcium chelator that may decrease Olr22 activity by altering intracellular calcium levels, which are crucial for the function and signaling of olfactory receptors. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may reduce Olr22 activity by inhibiting tyrosine kinases, which can control the phosphorylation status of proteins involved in olfactory receptor signaling. | ||||||